|
CHD7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.51579998237162E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53210000000326E-05 |
| Normal-vs-Stage2 |
2.15130000003061E-06 |
| Normal-vs-Stage3 |
6.20570039799873E-10 |
| Normal-vs-Stage4 |
3.34180000338691E-08 |
| Stage1-vs-Stage2 |
1.565000E-01 |
| Stage1-vs-Stage3 |
7.580100E-03 |
| Stage1-vs-Stage4 |
3.441900E-02 |
| Stage2-vs-Stage3 |
5.766000E-01 |
| Stage2-vs-Stage4 |
7.129200E-01 |
| Stage3-vs-Stage4 |
8.571800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.78630007954916E-10 |
| Normal-vs-AfricanAmerican |
5.734100E-02 |
| Normal-vs-Asian |
6.056000E-01 |
| Caucasian-vs-AfricanAmerican |
2.168300E-02 |
| Caucasian-vs-Asian |
8.561900E-02 |
| AfricanAmerican-vs-Asian |
6.630200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.27139981770586E-10 |
| Normal-vs-Female |
5.96699999999561E-05 |
| Male-vs-Female |
9.600000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.082500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.67900000000743E-06 |
| Normal-vs-Age(61-80Yrs) |
5.74350011994795E-10 |
| Normal-vs-Age(81-100Yrs) |
1.849610E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.334600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.331600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.593400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.222300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.382200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.238600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.632600E-01 |
| Normal-vs-Grade 2 |
7.56910000000444E-05 |
| Normal-vs-Grade 3 |
3.48110429371218E-12 |
| Normal-vs-Grade 4 |
3.0797999706067E-09 |
| Grade 1-vs-Grade 2 |
1.952070E-02 |
| Grade 1-vs-Grade 3 |
3.81409999999915E-05 |
| Grade 1-vs-Grade 4 |
1.992490E-04 |
| Grade 2-vs-Grade 3 |
1.704810E-03 |
| Grade 2-vs-Grade 4 |
4.835400E-03 |
| Grade 3-vs-Grade 4 |
3.726800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.94309999984799E-07 |
| Normal-vs-ccB subtype |
3.7066000002639E-07 |
| ccA subtype-vs-ccB subtype |
4.140800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86240000088489E-08 |
| Normal-vs-N1 |
2.444900E-03 |
| N0-vs-N1 |
7.286800E-01 |
|
|
